BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

367 related articles for article (PubMed ID: 26198300)

  • 21. Fascin-1 expression correlates with repression of E-cadherin expression in hepatocellular carcinoma cells and augments their invasiveness in combination with matrix metalloproteinases.
    Hayashi Y; Osanai M; Lee GH
    Cancer Sci; 2011 Jun; 102(6):1228-35. PubMed ID: 21323792
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Laminin-5 with transforming growth factor-beta1 induces epithelial to mesenchymal transition in hepatocellular carcinoma.
    Giannelli G; Bergamini C; Fransvea E; Sgarra C; Antonaci S
    Gastroenterology; 2005 Nov; 129(5):1375-83. PubMed ID: 16285938
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Kindlin-2 promotes hepatocellular carcinoma invasion and metastasis by increasing Wnt/β-catenin signaling.
    Lin J; Lin W; Ye Y; Wang L; Chen X; Zang S; Huang A
    J Exp Clin Cancer Res; 2017 Sep; 36(1):134. PubMed ID: 28969700
    [TBL] [Abstract][Full Text] [Related]  

  • 24. HSF1 promotes the inhibition of EMT-associated migration by low glucose via directly regulating Snail1 expression in HCC cells.
    Liu D; Sun L; Qin X; Liu T; Zhang S; Liu Y; Li S; Guo K
    Discov Med; 2016 Sep; 22(120):87-96. PubMed ID: 27755964
    [TBL] [Abstract][Full Text] [Related]  

  • 25. FGF19 promotes epithelial-mesenchymal transition in hepatocellular carcinoma cells by modulating the GSK3β/β- catenin signaling cascade via FGFR4 activation.
    Zhao H; Lv F; Liang G; Huang X; Wu G; Zhang W; Yu L; Shi L; Teng Y
    Oncotarget; 2016 Mar; 7(12):13575-86. PubMed ID: 26498355
    [TBL] [Abstract][Full Text] [Related]  

  • 26. MicroRNA-451: epithelial-mesenchymal transition inhibitor and prognostic biomarker of hepatocelluar carcinoma.
    Huang JY; Zhang K; Chen DQ; Chen J; Feng B; Song H; Chen Y; Zhu Z; Lu L; De W; Wang R; Chen LB
    Oncotarget; 2015 Jul; 6(21):18613-30. PubMed ID: 26164082
    [TBL] [Abstract][Full Text] [Related]  

  • 27. C5a receptor enhances hepatocellular carcinoma cell invasiveness via activating ERK1/2-mediated epithelial-mesenchymal transition.
    Hu WH; Hu Z; Shen X; Dong LY; Zhou WZ; Yu XX
    Exp Mol Pathol; 2016 Feb; 100(1):101-8. PubMed ID: 26475622
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Runt-related transcription factor 3 reverses epithelial-mesenchymal transition in hepatocellular carcinoma.
    Tanaka S; Shiraha H; Nakanishi Y; Nishina S; Matsubara M; Horiguchi S; Takaoka N; Iwamuro M; Kataoka J; Kuwaki K; Hagihara H; Toshimori J; Ohnishi H; Takaki A; Nakamura S; Nouso K; Yagi T; Yamamoto K
    Int J Cancer; 2012 Dec; 131(11):2537-46. PubMed ID: 22488108
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Hepatic stellate cell conditioned medium induces proliferation and epithelial-mesenchymal transition via activating ERK1/2 signaling pathway in hepatoma cells].
    Xie Y; Liao R; Pan L; Fan K; Peng C; Du C
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2017 Feb; 33(2):210-4. PubMed ID: 29762991
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cordycepin suppresses integrin/FAK signaling and epithelial-mesenchymal transition in hepatocellular carcinoma.
    Yao WL; Ko BS; Liu TA; Liang SM; Liu CC; Lu YJ; Tzean SS; Shen TL; Liou JY
    Anticancer Agents Med Chem; 2014 Jan; 14(1):29-34. PubMed ID: 23855336
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Epithelial-mesenchymal transition plays a critical role in drug resistance of hepatocellular carcinoma cells to oxaliplatin.
    Ma JL; Zeng S; Zhang Y; Deng GL; Shen H
    Tumour Biol; 2016 May; 37(5):6177-84. PubMed ID: 26614432
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The effect and mechanism of bufalin on regulating hepatocellular carcinoma cell invasion and metastasis via Wnt/β-catenin signaling pathway.
    Gai JQ; Sheng X; Qin JM; Sun K; Zhao W; Ni L
    Int J Oncol; 2016 Jan; 48(1):338-48. PubMed ID: 26648168
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Chemokine ligand 20 enhances progression of hepatocellular carcinoma via epithelial-mesenchymal transition.
    Hou KZ; Fu ZQ; Gong H
    World J Gastroenterol; 2015 Jan; 21(2):475-83. PubMed ID: 25593462
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Macrovascular Endothelial Cells Enhance the Motility of Liver Cancer Cells by Up-regulation of MMP-3, Activation of Integrin/FAK Signaling Pathway and Induction of Non-classical Epithelial-mesenchymal Transition.
    Ding SM; Lu AL; Lu JF; Chen XL; Edoo MIA; Zhou L; Xie HY; Zheng SS; Li QY
    J Cancer; 2020; 11(8):2044-2059. PubMed ID: 32127932
    [No Abstract]   [Full Text] [Related]  

  • 35. Wnt/β-catenin signaling enhances hypoxia-induced epithelial-mesenchymal transition in hepatocellular carcinoma via crosstalk with hif-1α signaling.
    Zhang Q; Bai X; Chen W; Ma T; Hu Q; Liang C; Xie S; Chen C; Hu L; Xu S; Liang T
    Carcinogenesis; 2013 May; 34(5):962-73. PubMed ID: 23358852
    [TBL] [Abstract][Full Text] [Related]  

  • 36. SOX18 Affects Cell Viability, Migration, Invasiveness, and Apoptosis in Hepatocellular Carcinoma (HCC) Cells by Participating in Epithelial-to-Mesenchymal Transition (EMT) Progression and Adenosine Monophosphate Activated Protein Kinase (AMPK)/Mammalian Target of Rapamycin (mTOR).
    Sun Y; Lei B; Huang Q
    Med Sci Monit; 2019 Aug; 25():6244-6254. PubMed ID: 31427562
    [TBL] [Abstract][Full Text] [Related]  

  • 37. ERK pathway activation contributes to the tumor-promoting effects of hepatic stellate cells in hepatocellular carcinoma.
    Xie YX; Liao R; Pan L; Du CY
    Immunol Lett; 2017 Aug; 188():116-123. PubMed ID: 28668554
    [TBL] [Abstract][Full Text] [Related]  

  • 38. M2-polarized tumor-associated macrophages facilitated migration and epithelial-mesenchymal transition of HCC cells via the TLR4/STAT3 signaling pathway.
    Yao RR; Li JH; Zhang R; Chen RX; Wang YH
    World J Surg Oncol; 2018 Jan; 16(1):9. PubMed ID: 29338742
    [TBL] [Abstract][Full Text] [Related]  

  • 39. GTSE1 promotes cell migration and invasion by regulating EMT in hepatocellular carcinoma and is associated with poor prognosis.
    Wu X; Wang H; Lian Y; Chen L; Gu L; Wang J; Huang Y; Deng M; Gao Z; Huang Y
    Sci Rep; 2017 Jul; 7(1):5129. PubMed ID: 28698581
    [TBL] [Abstract][Full Text] [Related]  

  • 40. miR-139-5p inhibits epithelial-mesenchymal transition, migration and invasion of hepatocellular carcinoma cells by targeting ZEB1 and ZEB2.
    Qiu G; Lin Y; Zhang H; Wu D
    Biochem Biophys Res Commun; 2015 Jul; 463(3):315-21. PubMed ID: 26022123
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.